SPEAC Trademark

Trademark Overview


On Tuesday, November 25, 2014, a trademark application was filed for SPEAC with the United States Patent and Trademark Office. The USPTO has given the SPEAC trademark a serial number of 86464930. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, August 16, 2021. This trademark is owned by International Myeloma Foundation. The SPEAC trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising and Business and Retail Services categories with the following description:

Downloadable fact sheets in the field of myeloma and cancer research, diagnosis and treatment; Downloadable podcasts in the field of myeloma and cancer research, diagnosis and treatment; Downloadable webcasts in the field of myeloma and cancer research, diagnosis and treatment; Downloadable webinars in the field of myeloma and cancer research, diagnosis and treatment; Downloadable written articles in the field of myeloma and cancer research, diagnosis and treatment

Association services, namely, promoting public awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens; Association services, namely, promoting the public interest and awareness in cancer research and education; Promoting awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens; Public advocacy to promote awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens
speac

General Information


Serial Number86464930
Word MarkSPEAC
Filing DateTuesday, November 25, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, August 16, 2021
Registration Number4776896
Registration DateTuesday, July 21, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2015

Trademark Statements


Goods and ServicesDownloadable fact sheets in the field of myeloma and cancer research, diagnosis and treatment; Downloadable podcasts in the field of myeloma and cancer research, diagnosis and treatment; Downloadable webcasts in the field of myeloma and cancer research, diagnosis and treatment; Downloadable webinars in the field of myeloma and cancer research, diagnosis and treatment; Downloadable written articles in the field of myeloma and cancer research, diagnosis and treatment
Goods and ServicesAssociation services, namely, promoting public awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens; Association services, namely, promoting the public interest and awareness in cancer research and education; Promoting awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens; Public advocacy to promote awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, December 4, 2014
Primary Code009
First Use Anywhere DateSaturday, June 30, 2012
First Use In Commerce DateSaturday, June 30, 2012

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, December 4, 2014
Primary Code035
First Use Anywhere DateThursday, September 6, 2012
First Use In Commerce DateThursday, September 6, 2012

Trademark Owner History


Party NameInternational Myeloma Foundation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStudio City, CA 91604

Party NameInternational Myeloma Foundation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Hollywood, CA 91607

Party NameInternational Myeloma Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Hollywood, CA 91607

Trademark Events


Event DateEvent Description
Tuesday, July 21, 2015REGISTERED-PRINCIPAL REGISTER
Monday, March 5, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 28, 2014NEW APPLICATION ENTERED
Thursday, December 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 9, 2015ASSIGNED TO EXAMINER
Wednesday, March 11, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 5, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 5, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 29, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 2, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 2, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, August 13, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, October 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 16, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 16, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, October 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, July 21, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, October 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED